REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka N 175 OOO (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: Apteka N 175 OOO Profile Updated: September 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Apteka N 175 OOO is an enterprise located in Russia, with the main office in Ryazan. It operates in the Pharmacies and Drug Stores industry. The enterprise was incorporated on January 05, 2003. In 2023, the company reported a net sales revenue drop of 6.37%. Over the same period, its total assets decreased by 22.79%. The net profit margin of Apteka N 175 OOO increased by 0.29% in 2023.

Headquarters
Trudovaya, 7
Ryazan; Ryazan Oblast; Postal Code: 390011

Contact Details: Purchase the Apteka N 175 OOO report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka N 175 OOO report to view the information.
Registered Capital:
Purchase the Apteka N 175 OOO report to view the information.
Incorporation Date:
January 05, 2003
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
71.44%
Purchase this report to view the information.
28.56%
Subsidiaries
Apteka N 175 OOO
32%
Company Performance
Financial values in the chart are available after Apteka N 175 OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-6.37%
Total operating revenue
-6.37%
Operating profit (EBIT)
82.26%
Net Profit (Loss) for the Period
40.1%
Total assets
-22.79%
Total equity
-50.59%
Operating Profit Margin (ROS)
2.13%
Net Profit Margin
0.29%
Return on Equity (ROE)
19.42%
Quick Ratio
-0.13%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?